Federal Initiative Against Microplastics Launched
On Thursday, as part of the Make America Healthy Again (MAHA) initiative, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. led a significant roundtable discussion addressing microplastic pollution in the U.S.
During the event, held at EPA headquarters, President Kennedy described the widespread presence of plastic in people’s bodies as a “generational health crisis,” associating these pollutants with chronic health issues, cognitive decline, and rising reproductive challenges.
The roundtable served as the debut of STOMP (Systematic Targeting Of MicroPlastics), a newly established program with a $144 million budget spearheaded by ARPA-H aimed at developing tools to measure, understand, and eliminate microplastics from both humans and water supplies.
Kennedy stressed that relying on “voluntary compliance” from the plastics industry is no longer sufficient. He introduced a comprehensive six-point regulatory strategy intended to close loopholes that have previously allowed harmful chemicals in food packaging to bypass thorough testing. He also noted that nearly all commercially available seafood now contains microplastics, which have increasingly been found in human arterial plaque and brain tissues.
Kennedy remarked, “We are confusing this agency. You can’t protect what you can’t measure. For decades, we’ve overlooked the ‘bioburden’ of plastics accumulating in our children’s bodies.”
Simultaneously, the EPA has made strides by including microplastics and various pharmaceuticals in the draft of the Sixth Contaminant Candidate List (CCL 6). This step is crucial for laying the groundwork for future federal regulations under the Safe Drinking Water Act, enabling the government to possibly impose legal limits on plastic levels in tap water.
Kennedy urged industry leaders to align with the growing consumer demand for safer alternatives, like glass and seaweed-based products, emphasizing his administration’s commitment to public health over corporate interests.
As part of the STOMP initiative, clinical trials will commence to measure individual plastic levels in the body, with the aim of creating scalable technologies to filter these persistent particulates from the environment and from human bodies.
